tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

RAIN

Rain Therapeutics Revamps Governance Post-Merger
Market NewsRain Therapeutics Revamps Governance Post-Merger
1y ago
8K
RAIN
Rain Therapeutics Updates Security Holder Rights
PremiumMarket News
Rain Therapeutics Updates Security Holder Rights
1y ago
8K
RAIN
Rain Therapeutics Announces Merger and Nasdaq Delisting
PremiumMarket News
Rain Therapeutics Announces Merger and Nasdaq Delisting
1y ago
8K
RAIN
Rain Therapeutics Merges with Pathos AI Subsidiary
PremiumMarket News
Rain Therapeutics Merges with Pathos AI Subsidiary
1y ago
8K
RAIN
Rain Therapeutics Enters Merger with Pathos AI Despite Legal Hurdles
PremiumMarket News
Rain Therapeutics Enters Merger with Pathos AI Despite Legal Hurdles
1y ago
8K
RAIN
Rain Therapeutics trading resumes
PremiumThe FlyRain Therapeutics trading resumes
1y ago
RAIN
Rain Oncology to be Acquired by Pathos AI for $1.16 in cash per share
Premium
The Fly
Rain Oncology to be Acquired by Pathos AI for $1.16 in cash per share
1y ago
RAIN
Rain Therapeutics trading halted, news pending
Premium
The Fly
Rain Therapeutics trading halted, news pending
1y ago
RAIN
Rain Oncology reports Q3 EPS (19c), consensus (27c)
PremiumThe Fly
Rain Oncology reports Q3 EPS (19c), consensus (27c)
1y ago
RAIN
Rain Oncology confirms receipt of unsolicited proposal from Concentra
PremiumThe Fly
Rain Oncology confirms receipt of unsolicited proposal from Concentra
1y ago
RAIN
Rain Oncology price target lowered to $1 from $1.50 at Citi
PremiumThe Fly
Rain Oncology price target lowered to $1 from $1.50 at Citi
2y ago
RAIN
Rain Oncology Plummets after Lead Candidate Disappoints in Phase 3
PremiumMarket News
Rain Oncology Plummets after Lead Candidate Disappoints in Phase 3
2y ago
RAIN
Roth MKM biotech analysts to hold analyst/industry conference call
PremiumThe FlyRoth MKM biotech analysts to hold analyst/industry conference call
2y ago
APGN
RAIN
Roth MKM biotech analysts to hold analyst/industry conference call
Premium
The Fly
Roth MKM biotech analysts to hold analyst/industry conference call
2y ago
APGN
RAIN
Roth MKM biotech analysts to hold analyst/industry conference call
Premium
The Fly
Roth MKM biotech analysts to hold analyst/industry conference call
2y ago
APGN
RAIN
Rain Oncology initiated with an Outperform at SVB Securities
PremiumThe Fly
Rain Oncology initiated with an Outperform at SVB Securities
2y ago
RAIN
Rain Oncology management to meet virtually with Piper Sandler
PremiumThe Fly
Rain Oncology management to meet virtually with Piper Sandler
2y ago
RAIN
Rain Oncology price target lowered to $24 from $29 at Citi
PremiumThe Fly
Rain Oncology price target lowered to $24 from $29 at Citi
2y ago
RAIN
Rain Oncology price target lowered to $17 from $18 at Mizuho
PremiumThe Fly
Rain Oncology price target lowered to $17 from $18 at Mizuho
2y ago
RAIN
Rain Oncology price target raised to $19 from $12 at H.C. Wainwright
PremiumThe FlyRain Oncology price target raised to $19 from $12 at H.C. Wainwright
2y ago
RAIN
Rain Oncology reports Q4 EPS (70c), consensus (56c)
Premium
The Fly
Rain Oncology reports Q4 EPS (70c), consensus (56c)
2y ago
RAIN
TipRanks ‘Perfect 10’ List: There’s an Opportunity Brewing in These 2 Stocks
Premium
Stock Analysis & Ideas
TipRanks ‘Perfect 10’ List: There’s an Opportunity Brewing in These 2 Stocks
2y ago
CABA
RAIN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >